Please provide your email address to receive an email when new articles are posted on . Participants who received the brief CBT had a markedly reduced risk for suicide attempts. Both treatment options ...
What Is Cognitive Rehabilitation for nrSPMS? Nonrelapsing secondary progressive multiple sclerosis (nrSPMS) comes with many challenges. One of the biggest can be its impact on your cognition, which ...
Cognitive impairment is a common but often overlooked symptom of schizophrenia. From difficulties in social settings to remembering how to take the bus to work, decreased cognitive function can ...
Many medical problems, such as traumatic brain injuries, stroke, dementia, and even cancer, can affect the brain and make it difficult for someone to think or process information. Cognitive ...
Communication is one of the major skills covered in cognitive behavioral therapy. Although therapy is often with an individual, relationship problems are a common focus of treatment. Helping someone ...
Cognitive processing therapy (CPT) is an evidence-based psychotherapy for post-traumatic stress disorder (PTSD). Its goal is to help people process traumatic events while challenging and changing ...
Sleep specialist S. Justin Thomas, Ph.D., has grown accustomed to people looking at him as though he is an eight-headed monster. That’s his way of referring to the reaction he gets from patients when ...
Rational emotive behavior therapy (REBT) is a therapy approach that focuses on managing irrational or unhealthy thoughts, emotions, and behaviors. In contrast to more passive talk therapy, REBT ...
Like all variants of cognitive behavioral therapy, cognitive behavioral therapy for psychosis (CBTp) is a short-term, structured form of psychotherapy based on the idea that the way someone thinks ...
Eight weeks of mindfulness or cognitive behavioral therapy were associated with improved pain, physical function and quality of life and reduced daily opioid dose in adults with chronic low back pain ...
Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics Among N = 300 patients, 74.7% was female, 76.5% was White, and 19.0% was ...